These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37408220)

  • 1. Aβ Oligomer Toxicity-Reducing Therapy for the Prevention of Alzheimer's Disease: Importance of the Nrf2 and PPARγ Pathways.
    Araki W
    Cells; 2023 May; 12(10):. PubMed ID: 37408220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer's Disease Dementia.
    Araki W; Kametani F
    Antioxidants (Basel); 2022 Jan; 11(1):. PubMed ID: 35052635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
    Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W
    Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoid-Derived Human Phenyl-γ-Valerolactone Metabolites Selectively Detoxify Amyloid-β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease.
    Ruotolo R; Minato I; La Vitola P; Artioli L; Curti C; Franceschi V; Brindani N; Amidani D; Colombo L; Salmona M; Forloni G; Donofrio G; Balducci C; Del Rio D; Ottonello S
    Mol Nutr Food Res; 2020 Mar; 64(5):e1900890. PubMed ID: 31914208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways.
    Takamura A; Sato Y; Watabe D; Okamoto Y; Nakata T; Kawarabayashi T; Oddo S; Laferla FM; Shoji M; Matsubara E
    Life Sci; 2012 Dec; 91(23-24):1177-86. PubMed ID: 22579764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
    Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W
    J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease.
    Gonçalves PB; Sodero ACR; Cordeiro Y
    Eur J Med Chem; 2024 Jul; 276():116684. PubMed ID: 39032401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
    Ma WH; Chen AF; Xie XY; Huang YS
    Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β oligomers in cellular models of Alzheimer's disease.
    Fontana IC; Zimmer AR; Rocha AS; Gosmann G; Souza DO; Lourenco MV; Ferreira ST; Zimmer ER
    J Neurochem; 2020 Nov; 155(4):348-369. PubMed ID: 32320074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
    Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
    J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells.
    Wang ZF; Li J; Ma C; Huang C; Li ZQ
    Biochem Pharmacol; 2020 Jan; 171():113674. PubMed ID: 31634455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ-oligomers: A potential therapeutic target for Alzheimer's disease.
    Ghosh S; Ali R; Verma S
    Int J Biol Macromol; 2023 Jun; 239():124231. PubMed ID: 36996958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
    Cline EN; Bicca MA; Viola KL; Klein WL
    J Alzheimers Dis; 2018; 64(s1):S567-S610. PubMed ID: 29843241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.
    Wilcox KC; Marunde MR; Das A; Velasco PT; Kuhns BD; Marty MT; Jiang H; Luan CH; Sligar SG; Klein WL
    PLoS One; 2015; 10(4):e0125263. PubMed ID: 25928376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.
    DiChiara T; DiNunno N; Clark J; Bu RL; Cline EN; Rollins MG; Gong Y; Brody DL; Sligar SG; Velasco PT; Viola KL; Klein WL
    Yale J Biol Med; 2017 Mar; 90(1):45-61. PubMed ID: 28356893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
    Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.